AKTX

AKTX

Akari Therapeutics plc ADS

$1.171+0.000 (0.017%)

Reaalajas hind

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$1.171

Kõrge

$1.171

Madal

$1.171

Maht

0.04M

Ettevõtte fundamentaalnäitajad

Kauplemisstatistika

Seotud uudised

GlobeNewswire

Akari Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Advancing development of novel Antibody Drug Conjugates (ADCs) with immuno-oncology payloads to treat multiple cancer tumors Rounding out executive team with deep oncology experience by appointing new Head of Business

Vaata rohkem
Akari Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire

Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development - Oncology

Global expertise in establishing and executing transformative transactions which have led to multiple approved therapeutic products Successful track record across oncology therapeutics including ADCs and antibody

Vaata rohkem
Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development - Oncology